Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

Articles published in
Anticancer Res
    August 2022
  1. SASAKI S, Nomura Y, Sudo T, Sakai H, et al
    Hematogenous Dissemination of Tumor Cells in Hepatocellular Carcinoma: Comparing Anterior and Non-anterior Approach Hepatectomy.
    Anticancer Res. 2022;42:4129-4137.
    >> Share

  2. IMAI N, Ishigami M, Oie Y, Kumagai M, et al
    Effectiveness of Porous Glass Membrane Pumping Emulsification Device in Transarterial Chemoembolization for Solitary Hepatocellular Carcinoma.
    Anticancer Res. 2022;42:3947-3951.
    >> Share

  3. SHIRAHAMA N, Goto Y, Sakai H, Fukutomi S, et al
    Liberal Application of Portal Vein Embolization for Right Hepatectomy Against Hepatocellular Carcinoma: Strategy to Achieve Zero Mortality for a Damaged Liver.
    Anticancer Res. 2022;42:4089-4095.
    >> Share

  4. WAKAME K, Sato K, Kasai M, Kikuchi E, et al
    Oral Administration of Mulberry (Morus alba L.) Leaf Powder Prevents the Development of Hepatocellular Carcinoma in Stelic Animal Model (STAM) Mice.
    Anticancer Res. 2022;42:4055-4062.
    >> Share

  5. JU M, Aoyama T, Komori K, Tamagawa H, et al
    The Albumin-Bilirubin Score Is a Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment.
    Anticancer Res. 2022;42:3929-3935.
    >> Share

  6. NOMURA Y, Akiba J, Yano H, Akagi Y, et al
    Fatty Liver Does Not Increase the Risk of Postoperative Liver Damage Following Hepatectomy.
    Anticancer Res. 2022;42:4159-4164.
    >> Share

    July 2022
  7. KANG BY, Kim SM, Hur W, Roh PR, et al
    Enhanced Tumoricidal Immune Responses by Transarterial Chemotherapy Using Novel Nanocomplexes in a Rat Liver Cancer Model.
    Anticancer Res. 2022;42:3463-3473.
    >> Share

  8. NAKASEKO Y, Furukawa K, Haruki K, Onda S, et al
    Standardized and Feasible Laparoscopic Approach for Tumors Located in the Caudate Lobe.
    Anticancer Res. 2022;42:3621-3625.
    >> Share

  9. HUDSON JM, Singh S, Milot L, Patel C, et al
    Dynamic Contrast-enhanced CT to Evaluate Early Response in Neuroendocrine Liver Metastases Treated With Everolimus and Radiation.
    Anticancer Res. 2022;42:3523-3527.
    >> Share

    June 2022
  10. MATSUMURA K, Yamamura K, Oda E, Akahoshi S, et al
    Successful Treatment of Intrahepatic Cholangiocarcinoma With Liver/Lung Metastasis and Peritoneal Dissemination After Liver Resection.
    Anticancer Res. 2022;42:3209-3215.
    >> Share

  11. HIDAKA M, Hara T, Soyama A, Sasaki R, et al
    The Outcome of Conversion Liver Resection Surgery by Lenvatinib Treatment: A Single Center Experience.
    Anticancer Res. 2022;42:3049-3054.
    >> Share

    May 2022
  12. HSIEH CH, Yeh CT, Huang YH, Lai MW, et al
    Circulating Tumor Cells Derived from Advanced Hepatocellular Carcinoma Rapidly Develop Resistance to Cytotoxic Chemotherapy.
    Anticancer Res. 2022;42:2479-2486.
    >> Share

  13. KUMAMOTO T, Matsuyama R, Takeda K, Sawada YU, et al
    Surgical Indications for Huge Hepatocellular Carcinoma.
    Anticancer Res. 2022;42:2573-2581.
    >> Share

  14. YANG CJ, Wu MH, Tsai JJ, Hsu FT, et al
    Inactivation of AKT/ERK Signaling and Induction of Apoptosis Are Associated With Amentoflavone Sensitization of Hepatocellular Carcinoma to Lenvatinib.
    Anticancer Res. 2022;42:2495-2505.
    >> Share

    April 2022
  15. KUZUYA T, Kawabe N, Hashimoto S, Funasaka K, et al
    Clinical Outcomes of Ramucirumab as Post-treatment Following Atezolizumab/Bevacizumab Combination Therapy in Advanced Hepatocellular Carcinoma.
    Anticancer Res. 2022;42:1905-1910.
    >> Share

  16. HANAKI T, Sunaguchi T, Goto K, Morimoto M, et al
    The Significance of Surgical Intervention for Metasynchronous Liver Metastasis in Gastric Cancer: A Single-centre Analysis.
    Anticancer Res. 2022;42:2177-2184.
    >> Share

  17. TOMITA K, Chiba N, Ochiai S, Gunji T, et al
    Prognostic Impact of N2 of the Primary Tumour in Surgical Resection for Colorectal Liver Metastases.
    Anticancer Res. 2022;42:1997-2001.
    >> Share

    March 2022
  18. KOMATSU S, Yano Y, Fujishima Y, Ishida J, et al
    Current Role of Atezolizumab Plus Bevacizumab Therapy in the Sequential Treatment of Unresectable Hepatocellular Carcinoma.
    Anticancer Res. 2022;42:1403-1412.
    >> Share

  19. HAMAYA S, Fujihara S, Iwama H, Fujita K, et al
    Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma Cells.
    Anticancer Res. 2022;42:1263-1275.
    >> Share

  20. MATSUMURA K, Yamamura K, Miyamoto H, Hara Y, et al
    Highly Advanced Colorectal Liver Metastases Successfully Treated With Fluorouracil Plus Leucovorin Monotherapy and Microwave Ablation.
    Anticancer Res. 2022;42:1645-1651.
    >> Share

  21. BARAK V, Kalickman I, Pe'er J
    sIL-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma.
    Anticancer Res. 2022;42:1447-1453.
    >> Share

  22. TASHIRO Y, Aoki T, Hirai T, Koizumi T, et al
    Indocyanine Green Labeling of Tumors in the Liver Recurring After Radiofrequency Ablation Enables Complete Resection by Fluorescence-guided Surgery.
    Anticancer Res. 2022;42:1345-1350.
    >> Share

    February 2022
  23. ICHIDA A, Akamatsu N, Nagata R, Mihara Y, et al
    Efficacy and Safety of Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Living Donor Liver Transplantation: A Report of Two Cases.
    Anticancer Res. 2022;42:1161-1167.
    >> Share

  24. ABE K, Maeda-Minami A, Ishizu T, Iwata S, et al
    Risk Factors for Hepatic Toxicity of High-dose Methotrexate in Patients With Osteosarcoma.
    Anticancer Res. 2022;42:1043-1050.
    >> Share

  25. FUJITA N, Handa A, Park JM
    Peritumoral Hyperintensity at Hepatobiliary Phase Gadoxetic Acid-enhanced MRI in Hepatic Neuroendocrine Tumors.
    Anticancer Res. 2022;42:911-917.
    >> Share

  26. JANG WI, Kim MS, Jeong JH, Kim W, et al
    Enhancement of Radiation Response Associated With Metformin in Hepatocellular Carcinoma: Preclinical Animal and Clinical Cohort Study.
    Anticancer Res. 2022;42:867-876.
    >> Share

  27. ZIOGAS IA, Schmitz R, Moris D, Vatsaas CJ, et al
    The Role of Surgery for Pancreatic Neuroendocrine Tumors.
    Anticancer Res. 2022;42:629-639.
    >> Share

    January 2022
  28. YAMAMURA K, Beppu T, Miyata T, Okabe H, et al
    Conversion Surgery for Hepatocellular Carcinoma Following Molecular Therapy.
    Anticancer Res. 2022;42:35-44.
    >> Share

  29. AURELLO P, Minervini A, Pace M, D'Angelo F, et al
    The Role of Surgery in the Treatment of Metachronous Liver Metastasis from Gastric Cancer: A Systematic Review.
    Anticancer Res. 2022;42:25-33.
    >> Share

  30. INOUE KI, Yamagishi H, Jojima T, Inoue T, et al
    Development of Non-alcoholic Steatohepatitis and Nodular Regenerative Hyperplasia in C57BL/6J Mice Fed a Fructose-containing Western Diet.
    Anticancer Res. 2022;42:609-617.
    >> Share

  31. JUNG JY, Koh SA, Lee KH, Kim JR, et al
    14-3-3 Sigma Protein Contributes to Hepatocyte Growth Factor-mediated Cell Proliferation and Invasion via Matrix Metalloproteinase-1 Regulation in Human Gastric Cancer.
    Anticancer Res. 2022;42:519-530.
    >> Share

  32. MIZUOCHI S, Akiba J, Kondo R, Kusano H, et al
    Clinicopathological Analysis of Non-B Non-C Hepatocellular Carcinoma Focusing on Cellular Proliferation.
    Anticancer Res. 2022;42:449-457.
    >> Share

  33. HARIMOTO N, Itoh S, Yamanaka T, Hagiwara K, et al
    Mac-2 Binding Protein Glycosylation Isomer as a Prognostic Marker for Hepatocellular Carcinoma With Sustained Virological Response.
    Anticancer Res. 2022;42:245-251.
    >> Share

  34. SHIMOZATO N, Namisaki T, Okano A, Ohana M, et al
    Efficacy and Safety of Lenvatinib for Patients With Advanced Hepatocellular Carcinoma: A Retrospective, Real-world Study Conducted in Japan.
    Anticancer Res. 2022;42:173-183.
    >> Share

    November 2021
  35. IMAI N, Yokoyama S, Yamamoto K, Ito T, et al
    Safety and Efficacy of Glass Membrane Pumping Emulsification Device in Transarterial Chemoembolization for Hepatocellular Carcinoma: First Clinical Outcomes.
    Anticancer Res. 2021;41:5817-5820.
    >> Share

  36. OMIYA S, Komatsu S, Kido M, Kuramitsu K, et al
    Impact of Sarcopenia as a Prognostic Factor on Reductive Hepatectomy for Advanced Hepatocellular Carcinoma.
    Anticancer Res. 2021;41:5775-5783.
    >> Share

  37. ADACHI Y, Yamamura K, Yumoto S, Higashi T, et al
    Far-advanced Colorectal Liver Metastases Successfully Managed With Modified ALPPS and Radiofrequency Ablation in Combination With Chemotherapy.
    Anticancer Res. 2021;41:5855-5861.
    >> Share

  38. FURUKAWA K, Onda S, Taniai T, Hamura R, et al
    Risk Factors and Overcoming Strategies of Surgical Site Infection After Hepatectomy for Colorectal Liver Metastases.
    Anticancer Res. 2021;41:5651-5656.
    >> Share

  39. MASATSUNE S, Kimura K, Kashiwagi S, En W, et al
    Impact of Intraoperative Blood Loss and Blood Transfusion on the Prognosis of Colorectal Liver Metastasis Following Curative Resection.
    Anticancer Res. 2021;41:5617-5623.
    >> Share

  40. TAGO T, Katsumata K, Udou R, Kasahara K, et al
    Significance of Radiofrequency Ablation for Unresectable Colorectal Cancer With Liver Metastases.
    Anticancer Res. 2021;41:5539-5547.
    >> Share

  41. TSOCHANTARIDIS I, Voulgaridou GP, Giatromanolaki A, Koukourakis MI, et al
    Profiling of Aldehyde Dehydrogenase Isoforms in In Vitro Formed Tumorspheres.
    Anticancer Res. 2021;41:5481-5488.
    >> Share

    October 2021
  42. ODA E, Yamamura K, Hara Y, Matsumura K, et al
    Intrahepatic Cholangiocarcinoma Coexisting With Multiple Bile Duct Adenoma Treated as Liver Metastasis from a Pancreatic Neuroendocrine Tumor.
    Anticancer Res. 2021;41:5249-5254.
    >> Share

  43. KIM M, Kim HC, Chung JW
    Chemoembolization for Hepatocellular Carcinoma in Patients With Inferior Vena Caval/Right Atrial Tumor Thrombi Without Hepatic Vein Invasion.
    Anticancer Res. 2021;41:5241-5247.
    >> Share

  44. MOON H, Park H, Ro SW
    c-Myc-driven Hepatocarcinogenesis.
    Anticancer Res. 2021;41:4937-4946.
    >> Share

    September 2021
  45. KOMATSU S, Yano Y, Kido M, Kuramitsu K, et al
    Lenvatinib Rechallenge After Ramucirumab Treatment Failure for Hepatocellular Carcinoma.
    Anticancer Res. 2021;41:4555-4562.
    >> Share

  46. OKAMOTO H, Shiba S, Iino H, Sudoh M, et al
    Tumor Vascular Microenvironment of Colorectal Hepatic Metastasis and Chemotherapy Response.
    Anticancer Res. 2021;41:4505-4513.
    >> Share

  47. TSUNEMATSU M, Onda S, Yanagaki M, Okui N, et al
    How to Perform Curative Laparoscopic Hepatectomy for Intraoperatively Unidentified Hepatocellular Carcinoma.
    Anticancer Res. 2021;41:4411-4416.
    >> Share

  48. TOKUDA K, Morine Y, Miyazaki K, Yamada S, et al
    Frailty Can Predict Prognosis After Hepatectomy in Patients With Colorectal Liver Metastasis.
    Anticancer Res. 2021;41:4637-4644.
    >> Share

    August 2021
  49. YAMANAKA M, Hayashi M, Yamada S, Sonohara F, et al
    A Possible Definition of Oligometastasis in Pancreatic Cancer and Associated Survival Outcomes.
    Anticancer Res. 2021;41:3933-3940.
    >> Share

  50. OURA K, Aoki T, Tashiro Y, Matsuda K, et al
    Indocyanine Green Fluorescence Image-guided Laparoscopic Hepatectomy Enabled Resection of a Tumor Invisible With Ultrasonography.
    Anticancer Res. 2021;41:3867-3869.
    >> Share

    July 2021
  51. KUBO H, Ikoma H, Yamamoto Y, Morimura R, et al
    Therapeutic Strategy of Colorectal Liver Metastasis Using Modified-JHBPS Nomogram.
    Anticancer Res. 2021;41:3657-3665.
    >> Share

  52. VIEIRA JF, Peixoto AP, Murta EFC, Michelin MA, et al
    Prophylactic Dendritic Cell Vaccination in Experimental Breast Cancer Controls Immunity and Hepatic Metastases.
    Anticancer Res. 2021;41:3419-3427.
    >> Share

    June 2021
  53. AU KY, Chan KK, Lo RC
    A Clinicopathological Study of Young-onset Hepatocellular Carcinoma.
    Anticancer Res. 2021;41:2933-2944.
    >> Share

    May 2021
  54. YAMAMURA K, Beppu T, Oda E, Sato N, et al
    Hepatic Inflammatory Pseudotumor Mimicking Malignant Tumor With Rare Onset of Intra-abdominal Hemorrhage.
    Anticancer Res. 2021;41:2727-2732.
    >> Share

  55. KIM HC, Choi JW, Lee M, Kim YJ, et al
    Yttrium-90 Radioembolization for Hepatocellular Carcinoma: Virtual Tumor Absorbed Dose as a Predictor of Complete Response.
    Anticancer Res. 2021;41:2625-2635.
    >> Share

  56. YAMAMOTO T, Imai N, Yamamoto K, Ito T, et al
    Tolerability of Molecular-targeted Agents for Hepatocellular Carcinoma Treatment in Haemophiliacs.
    Anticancer Res. 2021;41:2569-2573.
    >> Share

  57. ISHIGAMI I, Shuwari N, Kaminade T, Mizuguchi H, et al
    A TGFbeta Signaling Inhibitor, SB431542, Inhibits Reovirus-mediated Lysis of Human Hepatocellular Carcinoma Cells in a TGFbeta-independent Manner.
    Anticancer Res. 2021;41:2431-2440.
    >> Share

  58. SHIBUTANI M, Kimura K, Kashiwagi S, Wang EN, et al
    Elevated Postoperative Levels of Serum C-reactive Protein Are Associated With Shorter Long-term Survival After Resection of Colorectal Liver Metastases, Regardless of the Occurrence of Infectious Complications.
    Anticancer Res. 2021;41:2605-2610.
    >> Share

  59. NISHIKAWA H, Fukunishi S, Asai A, Nishiguchi S, et al
    Obesity and Liver Cancer in Japan: A Comprehensive Review.
    Anticancer Res. 2021;41:2227-2237.
    >> Share

    April 2021
  60. MAESAKA K, Sakamori R, Yamada R, Tahata Y, et al
    Efficacy of Ramucirumab Versus Sorafenib as Subsequent Treatment for Hepatocellular Carcinoma.
    Anticancer Res. 2021;41:2187-2192.
    >> Share

  61. FURUKAWA K, Haruki K, Yasuda J, Onda S, et al
    Strategies to Perform Curative Laparoscopic Repeat Hepatectomy for Recurrent Liver Tumors After Open Right Lobectomy.
    Anticancer Res. 2021;41:2171-2175.
    >> Share

  62. SASAKI R, Fukushima M, Haraguchi M, Miuma S, et al
    Liver Function in Older Patients With Unresectable Hepatocellular Carcinoma After Administration of Lenvatinib.
    Anticancer Res. 2021;41:2025-2032.
    >> Share

  63. SHAO C, Shao PP, Chen WT, Lin CC, et al
    Direct-acting Antiviral Therapy Improves the Outcome of Chronic Hepatitis C/intermediate-stage B Hepatocellular Carcinoma Patients.
    Anticancer Res. 2021;41:2007-2016.
    >> Share

  64. YASUHARA Y, Komatsu S, Kuramitsu K, Kido M, et al
    Feasibility of Reductive Hepatectomy in Patients With BCLC B and C Hepatocellular Carcinoma.
    Anticancer Res. 2021;41:1975-1983.
    >> Share

  65. LEE GW, Hur W, Kim JH, Park DJ, et al
    Nardostachys jatamansi Root Extract Attenuates Tumor Progression in Hepatocellular Carcinoma via Inhibition of ERK/STAT3 Pathways.
    Anticancer Res. 2021;41:1883-1893.
    >> Share

  66. NISHINO H, Okuno M, Seo S, Toda R, et al
    Sinusoidal Obstruction Syndrome Promotes Liver Metastatic Seeding of Colorectal Cancer Cells in a Rat Model.
    Anticancer Res. 2021;41:1803-1810.
    >> Share

  67. SHIBA S, Shibuya K, Okamoto M, Okano N, et al
    Carbon-ion Radiotherapy for Oligometastatic Colorectal Cancer in the Liver or Lung.
    Anticancer Res. 2021;41:1997-2005.
    >> Share

    March 2021
  68. PERL RM, Portugall J, Hinterleitner C, Hinterleitner M, et al
    Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases.
    Anticancer Res. 2021;41:1451-1458.
    >> Share

  69. PARK SY, Seo YR, Ko MJ, Lee JH, et al
    Targeting CALM2 Inhibits Hepatocellular Carcinoma Growth and Metastasis by Suppressing E2F5-mediated Cell Cycle Progression.
    Anticancer Res. 2021;41:1315-1325.
    >> Share

  70. AKIBA J, Yoshida T, Sadashima E, Murata K, et al
    The Expression of PEDF and its Putative Receptors in Hepatocellular Carcinoma and Background Liver Tissue.
    Anticancer Res. 2021;41:1203-1212.
    >> Share

  71. NAKANISHI Y, Hirota S, Hojo Y, Nakamura T, et al
    Pathological Complete Remission of Liver Metastases Correlates With Elimination of Tumor-infiltrating Tregs in Gastric Cancer.
    Anticancer Res. 2021;41:1571-1577.
    >> Share

  72. HIROSE Y, Sakata J, Kobayashi T, Miura K, et al
    NQO1 as a Marker of Chemosensitivity and Prognosis for Colorectal Liver Metastasis.
    Anticancer Res. 2021;41:1563-1570.
    >> Share

    February 2021
  73. LEE HP, Tsai KW, Lee CC
    Prognostic Influence of Cytoplasmic/Nuclear Hepatoma-derived Growth Factor in Head and Neck Cancer.
    Anticancer Res. 2021;41:803-810.
    >> Share

  74. OSAWA M, Matsuda Y, Kinoshita Y, Wakai T, et al
    Urokinase-type Plasminogen Activator Is a Therapeutic Target for Overcoming Sorafenib Resistance in Hepatoma Cells.
    Anticancer Res. 2021;41:645-660.
    >> Share

  75. KABADI SM, Byfield SD, LE L, Olufade T, et al
    Adverse Events and Economic Burden Among Patients Receiving Systemic Treatment for Mantle Cell Lymphoma: A Real-World Retrospective Cohort Study.
    Anticancer Res. 2021;41:927-936.
    >> Share

    January 2021
  76. SAITO R, Amemiya H, Hosomura N, Kawaida H, et al
    Stroke Volume Variation Monitoring to Minimize Blood Loss in Hepatocellular Carcinoma Resection.
    Anticancer Res. 2021;41:409-415.
    >> Share

  77. AMEMIYA H, Matsuda M, Saito R, Hosomura N, et al
    Impact of Insulin Treatment on Prognosis of non-B non-C Hepatocellular Carcinoma After Hepatectomy.
    Anticancer Res. 2021;41:317-326.
    >> Share

  78. FABRITIUS MP, Hartmann F, Seidensticker R, Pech M, et al
    Liver Function Changes After Technetium-99m-Macroaggregated Albumin Administration and Their Predictive Value Regarding Hepatotoxicity in Patients Undergoing Yttrium-90-Radioembolization.
    Anticancer Res. 2021;41:437-444.
    >> Share

  79. KIM EJ, Kim M, Seo S, Kim MJ, et al
    Comparison of Sinusoidal Obstruction Syndrome in Gastric Cancer Patients Receiving S-1/oxaliplatin Versus Capecitabine/oxaliplatin.
    Anticancer Res. 2021;41:391-402.
    >> Share

    December 2020
  80. CHEN SY, Chao CN, Huang HY, Fang CY, et al
    Flavopereirine Inhibits Hepatocellular Carcinoma Cell Growth by Inducing Cell-cycle Arrest, Apoptosis, and Autophagy-related Protein Expression.
    Anticancer Res. 2020;40:6907-6914.
    >> Share

  81. LLUCH P, Segarra G, Tosca J, Navarro L, et al
    Oxidative and Nitrosative Pattern in Circulating Leukocytes of Very Early/Early Hepatocellular Carcinoma Patients.
    Anticancer Res. 2020;40:6853-6861.
    >> Share

  82. ABREU P, Ferreira R, Mineli V, Ribeiro MA, et al
    Alternative Biomarkers to Predict Tumor Biology in Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:6573-6784.
    >> Share

  83. SATO N, Yamamura K, Oda E, Akahoshi S, et al
    Cholangiolocarcinoma With Multiple Recurrences Successfully Treated With Repeated Liver Resection and Radiofrequency Ablation.
    Anticancer Res. 2020;40:7147-7153.
    >> Share

  84. YAMAMOTO J, Sugisawa N, Hamada K, Nishino H, et al
    A Universal Gelfoam 3-D Histoculture Method to Establish Patient-derived Cancer Cells (3D-PDCC) Without Fibroblasts from Patient-derived Xenografts.
    Anticancer Res. 2020;40:6765-6768.
    >> Share

  85. NAKAGAWA N, Tanaka K, Sonohara F, Kandimalla R, et al
    Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue.
    Anticancer Res. 2020;40:6665-6676.
    >> Share

  86. PALEK R, Rosendorf J, Maleckova A, Vistejnova L, et al
    Influence of Mesenchymal Stem Cell Administration on The Outcome of Partial Liver Resection in a Porcine Model of Sinusoidal Obstruction Syndrome.
    Anticancer Res. 2020;40:6817-6833.
    >> Share

    November 2020
  87. YAMAMURA K, Beppu T, Kinoshita K, Oda E, et al
    Hepatocellular Carcinoma With Extensive Cancer-associated Thrombosis Successfully Treated With Liver Resection and Direct Oral Anticoagulant: A Case Report.
    Anticancer Res. 2020;40:6465-6471.
    >> Share

  88. DAHLQUIST KJV, Voth LC, Fee AJ, Stoeckman AK, et al
    An Autocrine Role for CXCL1 in Progression of Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:6075-6081.
    >> Share

  89. TOMIOKA K, Aoki T, Matsuda K, Fujimori A, et al
    Usefulness of a Transumbilical Incision for Organ Removal in Laparoscopic Hepatectomy.
    Anticancer Res. 2020;40:6545-6550.
    >> Share

  90. AHMED A, Halama N
    Tertiary Lymphoid Structures in Colorectal Cancer Liver Metastases: Association With Immunological and Clinical Parameters and Chemotherapy Response.
    Anticancer Res. 2020;40:6367-6373.
    >> Share

    October 2020
  91. YAMAMURA K, Beppu T, Sato N, Kinoshita K, et al
    Complete Removal of Adrenal Metastasis in Hepatocellular Carcinoma Using Indocyanine Green Fluorescent Imaging.
    Anticancer Res. 2020;40:5823-5828.
    >> Share

  92. SUGISAWA N, Nishino H, Higuchi T, Park JH, et al
    A Gemcitabine Plus 5-Fluorouracil Combination Inhibits Gastric-Cancer Liver Metastasis in a PDOX Model: A Novel Treatment Strategy.
    Anticancer Res. 2020;40:5393-5397.
    >> Share

    September 2020
  93. NARITA R, Kotoh K, Yoneda A, Motomura M, et al
    Factors Raising Serum Ammonia Level During Lenvatinib Treatment of Patients With Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:5271-5276.
    >> Share

  94. GABATA R, Harada K, Mizutani Y, Ouchi H, et al
    Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against beta-Catenin-activated Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:5211-5219.
    >> Share

  95. NAKURA M, Miyashita T, Yamamoto Y, Takada S, et al
    Inhibitory Effects of Beraprost Sodium in Murine Hepatic Sinusoidal Obstruction Syndrome.
    Anticancer Res. 2020;40:5171-5180.
    >> Share

  96. WU TK, Chen CH, Lee WT, Su TF, et al
    Cetyltrimethylammonium Bromide Suppresses the Migration and Invasion of Hepatic Mahlavu Cells by Modulating Fibroblast Growth Factor Signaling.
    Anticancer Res. 2020;40:5059-5069.
    >> Share

  97. OWADA S, Endo H, Okada C, Yoshida K, et al
    Setanaxib as a Potent Hypoxia-specific Therapeutic Agent Against Liver Cancer.
    Anticancer Res. 2020;40:5071-5079.
    >> Share

    August 2020
  98. GOTO Y, Hisaka T, Sakai H, Takagi K, et al
    Salvage Surgery for Initially Unresectable Locally Advanced Hepatocellular Carcinoma Downstaged by Hepatic Arterial Infusion Chemotherapy.
    Anticancer Res. 2020;40:4773-4777.
    >> Share

  99. KOJIMA S, Hisaka T, Midorikawa R, Naito Y, et al
    Prognostic Impact of Desmoplastic Reaction Evaluation for Intrahepatic Cholangiocarcinoma.
    Anticancer Res. 2020;40:4749-4754.
    >> Share

  100. HAN YH, Li WL, Jin MH, Jin YH, et al
    Peroxiredoxin II Inhibits Alcohol-induced Apoptosis in L02 Hepatocytes Through AKT/beta-Catenin Signaling Pathway.
    Anticancer Res. 2020;40:4491-4504.
    >> Share

  101. KWON JH, Yoo SH, Nam SW, Lee YJ, et al
    Diagnostic Role of Contrast-enhanced Ultrasound in the Discrimination of Malignant Portal Vein Thrombosis in Patients With Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:4351-4363.
    >> Share

  102. HARIMOTO N, Araki K, Ishii N, Muranushi R, et al
    Predictors of Postoperative Ascites After Hepatic Resection in Patients With Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:4343-4349.
    >> Share

  103. HEINZE C, Omari J, Damm R, Hass P, et al
    Interstitial Brachytherapy for Limited (<4 cm) and Large (>/=4 cm) Hepatic Metastases from Rare and Less Common Cancers.
    Anticancer Res. 2020;40:4281-4289.
    >> Share

  104. YUE CH, Chen CH, Lee WT, Su TF, et al
    Cetyltrimethylammonium Bromide Disrupts the Mesenchymal Characteristics of HA22T/VGH Cells Via Inactivation of c-Met/PI3K/Akt/mTOR Pathway.
    Anticancer Res. 2020;40:4513-4522.
    >> Share

  105. HISAKA T, Sakai H, Sato T, Goto Y, et al
    Quercetin Suppresses Proliferation of Liver Cancer Cell Lines In Vitro.
    Anticancer Res. 2020;40:4695-4700.
    >> Share

    July 2020
  106. KIM HC, Joo I, Lee M, Kim YJ, et al
    Radioembolization-induced Tumor Calcifications as a Surrogate Marker of Tumor Response in Patients With Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:4191-4198.
    >> Share

  107. AMANUMA M, Nagai H, Igarashi Y
    Sorafenib Might Induce Sarcopenia in Patients With Hepatocellular Carcinoma by Inhibiting Carnitine Absorption.
    Anticancer Res. 2020;40:4173-4182.
    >> Share

  108. NAKAMURA M, Ueno M, Hayami S, Kawai M, et al
    Effective Response of Intrahepatic Cholangiocarcinoma to Pembrolizumab: A Case Report.
    Anticancer Res. 2020;40:4123-4129.
    >> Share

  109. SHIOGA T, Kondo R, Ogasawara S, Akiba J, et al
    Usefulness of Tumor Tissue Biopsy for Predicting the Biological Behavior of Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:4105-4113.
    >> Share

  110. SAKURAOKA Y, Kubota K, Tanaka G, Shimizu T, et al
    Features of Hepatocellular Carcinoma With Micro Hepatic Vein Invasion and their Correlation With Hepatitis B and C Virus.
    Anticancer Res. 2020;40:3983-3990.
    >> Share

  111. MORIGUCHI M, Aramaki T, Sato R, Iwai K, et al
    Intrahepatic Tumor Burden as a Novel Factor Influencing the Introduction of Second-line Chemotherapy for Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:3953-3960.
    >> Share

  112. IGUCHI T, Sugimachi K, Mano Y, Motomura T, et al
    Prognostic Impact of Geriatric Nutritional Risk Index in Patients With Synchronous Colorectal Liver Metastasis.
    Anticancer Res. 2020;40:4165-4171.
    >> Share

  113. TASHIRO Y, Aoki T, Hirai T, Koizumi T, et al
    Pathological Validity of Using Near-infrared Fluorescence Imaging for Securing Surgical Margins During Liver Resection.
    Anticancer Res. 2020;40:3873-3882.
    >> Share

  114. XIE DP, Gong YX, Jin YH, Ren CX, et al
    Anti-tumor Properties of Picrasma quassioides Extracts in H-Ras(G12V) Liver Cancer Are Mediated Through ROS-dependent Mitochondrial Dysfunction.
    Anticancer Res. 2020;40:3819-3830.
    >> Share

    June 2020
  115. MIYATA T, Takamura H, Kin R, Nishiki H, et al
    Spleen Volume as a Predictive Biomarker for Thrombocytopenia and Liver Dysfunction After Oxaliplatin-based Chemotherapy.
    Anticancer Res. 2020;40:3361-3370.
    >> Share

  116. BAE KB, Kim SH, Kang MS, Kim DH, et al
    An Animal Model of Colorectal Cancer Liver Metastasis With a High Metastasis Rate and Clonal Dynamics.
    Anticancer Res. 2020;40:3297-3306.
    >> Share

    May 2020
  117. KAIDA T, Beppu T, Hayashi H, Imai K, et al
    Inflammatory Liver Tumor Caused by Fasciola hepatica Mimicking Intrahepatic Cholangiocarcinoma.
    Anticancer Res. 2020;40:2795-2800.
    >> Share

  118. LIM SC, Parajuli KR, Han SI
    Role of Death Receptors-associated Lipid Rafts in Oxaliplatin-induced Death Mode Regulation of HepG2 Cells.
    Anticancer Res. 2020;40:2573-2582.
    >> Share

    April 2020
  119. KUZUYA T, Ishigami M, Ito T, Ishizu Y, et al
    Sorafenib vs. Lenvatinib as First-line Therapy for Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis.
    Anticancer Res. 2020;40:2283-2290.
    >> Share

  120. LIU LI, Ahn E, Studeman K, Campbell K, et al
    Primary Hepatic Carcinosarcoma Composed of Hepatocellular Carcinoma, Cholangiocarcinoma, Osteosarcoma and Rhabdomyosarcoma With Poor Prognosis.
    Anticancer Res. 2020;40:2225-2229.
    >> Share

  121. KUZUYA T, Ishigami M, Ito T, Ishizu Y, et al
    Initial Experience of Ramucirumab Treatment After Lenvatinib Failure for Patients With Advanced Hepatocellular Carcinoma.
    Anticancer Res. 2020;40:2089-2093.
    >> Share

  122. JELSKI W, Piechota J, Orywal K, Mroczko B, et al
    The Alterations in Alcohol Dehydrogenase Activity in the Sera of Women With Intrahepatic Cholestasis of Pregnancy.
    Anticancer Res. 2020;40:1997-2001.
    >> Share

  123. LEE J, Seo G, Hur W, Yoon SK, et al
    SRSF3 Depletion Leads to an Increase in SF3B4 Expression in SNU-368 HCC Cells.
    Anticancer Res. 2020;40:2033-2042.
    >> Share

    March 2020
  124. ZARLING L, Emamekhoo H, Bhutani G, Ziemlewicz T, et al
    Polycystic Liver Disease in a Patient With Metastatic Renal Cell Carcinoma: A Case Report.
    Anticancer Res. 2020;40:1527-1534.
    >> Share

  125. PALKOVICS A, Vereczkei A, Fincsur A, Kiss I, et al
    Short- and Long-term Histological Changes in Liver Parenchyma After Different Resection Methods and Their Potential Role in Treatment of Colorectal Liver Metastasis.
    Anticancer Res. 2020;40:1359-1365.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016